Streetwise Reports: The Gold Report, The Energy Report, The Life Sciences Report and Streetwise Reports
755 Baywood Dr, Second Floor
Petaluma, CA 94954
(707) 981-8999 ext: 327
Streetwise Reports: The Gold Report, The Energy Report, The Life Sciences Report and Streetwise Reports are free publications of Streetwise Reports. If you would like to subscribe, please complete our online form.
Interested in becoming a sponsor or an Advertiser?
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
|"DRRX has received an upfront payment of $12.5 million, and is also eligible for $5 million in the event of FDA approval for Indivior's RBP-7000."|
|RP's Phase 1/2a trial for tendon repair in chronic Achilles tendinosis met its goal and established a complete safety profile at six months that showed no serious adverse events."|
|"We believe this newer Alzheimer's theory creates a path to develop a unique disease-modifying Alzheimer's treatment, PMN's PMN310, which has best-in-class potential."|
|"We think the patent purchase agreement is a great deal for DRRX."|